115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epcoritamab with rituximab + lenalidomide (R(2)) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7
    Meeting Abstract

    Lori, L. A.; Falchi, L.; Vermaat, J. S. P.; Musuraca, G.; Belada, D.; Nijland, M.; Christensen, J. H.; Offner, F.; Hoehn, D.; Marek, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma
    Meeting Abstract

    Mora, J.; Chan, G. C.; Morgenstern, D. A.; Amoroso, L.; Nysom, K.; Faber, J.; Wingerter, A.; Bear, M.; Rubio-San-Simón, A.; Eldridge, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Enfortumab vedotin (EV) in previously treated gastric/esophageal cancers cohorts of EV-202
    Meeting Abstract

    Muro, K.; Chin, K.; Maron, S. B.; Braiteh, F. S.; Mitani, S.; Hara, H.; Kuboki, Y.; Mulcahy, M. F.; Baranda, J. C.; Gardner, F. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic profiling in a subgroup analysis of patients (pts) with diffuse large B-cell lymphoma (DLBCL) and extranodal (EN) sites of involvement in the phase 3 Pola-R-CHP versus R-CHOP (POLARIX) study
    Meeting Abstract

    Lue, J. K.; Morschhauser, F.; Tilly, H.; Lenz, G.; Jardin, F.; Herrera, A. F.; Sharman, J. P.; Flowers, C.; Friedberg, J. W.; Trneny, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Outcomes with perioperative durvalumab (D) in pts with resectable NSCLC and baseline N2 lymph node involvement (N2 R-NSCLC): An exploratory subgroup analysis of AEGEAN
    Meeting Abstract

    Heymach, J.; Reck, M.; Mitsudomi, T.; Taube, J. M.; Spira, A. I.; Chaft, J. E.; Doherty, G. J.; Mann, H.; Fouad, T. M.; Harpole, D. H.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Proteomic analysis in patients with dedifferentiated liposarcoma (DDLPS) in a phase Ia/Ib study of the MDM2-p53 antagonist brigimadlin
    Meeting Abstract

    Jaimes, Y.; LoRusso, P.; Sturm, G.; Gounder, M. M.; Yamamoto, N.; Somaiah, N.; Lugowska, I. A.; Moreno, V.; Peltzer, A.; Teufel, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Biomarker analyses in patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial
    Meeting Abstract

    Motzer, R. J.; Porta, C.; Eto, M.; Hutson, T. E.; Rha, S. Y.; Merchan, J. R.; Winquist, E.; Gurney, H.; Grünwald, V.; George, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Sotorasib plus carboplatin and pemetrexed in KRAS G12C advanced NSCLC: Updated analysis from the international CodeBreaK 101 trial
    Meeting Abstract

    Li, B. T.; Clarke, J. M.; Felip, E.; Ruffinelli, J. C.; Garrido, P.; Zugazagoitia, J.; Goldberg, S. B.; Ramalingam, S. S.; Victoria, I.; Puri, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • ETHAN: A phase II study comparing different endocrine therapies for male breast cancer
    Meeting Abstract

    Leone, J. P.; Ruddy, K. J.; Rashid, N.; Giordano, S. H.; Gupta, G. P.; Hilsenbeck, S. G.; Gucalp, A.; Walsh, E. M.; Sukumar, J. S.; Makhlin, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cancer burden across South Asia in 2020: A global cancer observatory analysis
    Meeting Abstract

    Jain, U.; Rahim, F.; Jain, B.; Arkalgud, A.; Sabat, C.; Hammond, A.; Tshering, P.; Patel, T. A.; Sirohi, B.; Jain, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save